Search results
8 lip 2022 · NEW YORK and MAINZ, GERMANY, July 8, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the U.S. Food and Drug Administration (FDA) approved the companies’ supplemental Biologics License Application (sBLA) for their COVID-19 vaccine, known as COMIRNATY® (COVID-19 Vaccine, mRNA), to include individuals 12 through ...
Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty...
Today, the FDA amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 16 and 17...
Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single)...
8 lip 2022 · July 8 (Reuters) - The U.S. Food and Drug Administration said on Friday it has granted full approval to Pfizer (PFE.N) and BioNTech's COVID-19 vaccine for adolescents aged between 12 and 15...
23 sie 2021 · The U.S. drug regulator on Monday granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine - the first to secure such Food and Drug Administration validation - prompting President Joe...
Fortunately, just days into the new year, the U.S. Food and Drug Administration (FDA) granted our request for emergency use authorization of a booster dose of our original COVID–19 vaccine for ages 12 years and older. The development and testing of new vaccines tailored specifically to the Omicron variant were underway here at Pfizer, but ...
